After 'bad launch' remark by CEO, Pfizer's RSV vaccine gains traction in Q4. How will it fare in latest round of GSK showdown? 0 30.01.2024 16:58 Fiercepharma.com After 'bad launch' remark by CEO, Pfizer's RSV vaccine gains traction in Q4. How will it fare in latest round of GSK showdown? kdunleavy Tue, 01/30/2024 - 08:58 Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
